AC Immune SA (ACIU)
USD 2.77
(-5.78%)
USD 2.77
(-5.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -60.4 Million | -73.56 Million | -65.68 Million | -59.51 Million | 55.22 Million | -44.07 Million |
| Net Income | -54.23 Million | -70.75 Million | -72.99 Million | -61.92 Million | 45.44 Million | -50.95 Million |
| Depreciation & Amortization | 2.21 Million | 2.35 Million | 2.4 Million | 1.96 Million | 1.69 Million | 961 Thousand |
| Deferred income taxes | 1.3 Million | - | 130 Thousand | 371 Thousand | 509 Thousand | 131 Thousand |
| Stock-based compensation | 4.73 Million | 3.33 Million | 4.12 Million | 4.08 Million | 2.83 Million | 2.51 Million |
| Change in working capital | -15.16 Million | -8.43 Million | 6.84 Million | -4.57 Million | 5.65 Million | 1.81 Million |
| Other non-cash items | 1.09 Million | -72 Thousand | -6.19 Million | 551 Thousand | -909 Thousand | 1.45 Million |
| Investing Cash Flow | 65.64 Million | 23.76 Million | -53.66 Million | 28.32 Million | -66.88 Million | -32.03 Million |
| Investments in PPE | -801 Thousand | -1.23 Million | -2.63 Million | -1.7 Million | -1.88 Million | -1.85 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | -65 Million | -30 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 66.44 Million | 25 Million | -51.02 Million | 30.03 Million | -65 Million | -178 Thousand |
| Financing Cash Flow | 43.25 Million | -1.34 Million | 40.74 Million | -803 Thousand | 49.61 Million | 109.37 Million |
| Debt repayment | -548 Thousand | -569 Thousand | -513 Thousand | -432 Thousand | -420 Thousand | -339 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -8000.00 | - | -100 Thousand | - | - |
| Common Stock Issuance | 43.79 Million | 7000.00 | 16.72 Million | 100 Thousand | - | 111.53 Million |
| Other Financing Activities | 43.79 Million | -777 Thousand | 24.53 Million | -271 Thousand | 50.03 Million | -1.81 Million |
| Accounts receivables | -14.8 Million | 36 Thousand | -99 Thousand | -25 Thousand | -68 Thousand | 698 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -360 Thousand | -8.46 Million | 6.94 Million | -4.54 Million | 5.71 Million | 1.81 Million |
| Cash at beginning of period | 31.58 Million | 82.21 Million | 160.89 Million | 193.58 Million | 156.46 Million | 124.37 Million |
| Cash at end of period | 78.49 Million | 31.58 Million | 82.21 Million | 160.89 Million | 193.58 Million | 156.46 Million |
| Capital Expenditure | -801 Thousand | -1.23 Million | -2.63 Million | -1.7 Million | -1.88 Million | -1.85 Million |
| Effect of forex changes on cash | -1.57 Million | 521 Thousand | -70 Thousand | -703 Thousand | -826 Thousand | -1.17 Million |
| Net cash flow / Change in cash | 46.9 Million | -50.63 Million | -78.67 Million | -32.69 Million | 37.12 Million | 32.08 Million |
| Free Cash Flow | -61.2 Million | -74.8 Million | -68.32 Million | -61.22 Million | 53.33 Million | -45.93 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -22.76 Million | -17.86 Million | -4.74 Million | -54.23 Million | -15.14 Million | -16.83 Million |
| Depreciation & Amortization | 548 Thousand | 556 Thousand | 555 Thousand | 2.21 Million | 549 Thousand | 541 Thousand |
| Deferred income taxes | - | - | 506 Thousand | 1.3 Million | 171 Thousand | 530 Thousand |
| Stock-based compensation | 608 Thousand | 1.88 Million | 797 Thousand | 4.36 Million | 867 Thousand | 1.22 Million |
| Change in working capital | 91.22 Million | 18.11 Million | -14.62 Million | -15.16 Million | 467 Thousand | 462 Thousand |
| Other non-cash items | 2.21 Million | -2.03 Million | 1.31 Million | 1.09 Million | -211 Thousand | -45 Thousand |
| Investing Cash Flow | -75.81 Million | -23.56 Million | 23.28 Million | 65.64 Million | 4.72 Million | -5.15 Million |
| Investments in PPE | -68 Thousand | -249 Thousand | -166 Thousand | -801 Thousand | -280 Thousand | -155 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -75.74 Million | -54 Thousand | 23.44 Million | 66.44 Million | 5 Million | -5 Million |
| Financing Cash Flow | -62 Thousand | -688 Thousand | 41.02 Million | 43.25 Million | 448 Thousand | 1.91 Million |
| Debt repayment | -173 Thousand | -167 Thousand | -139 Thousand | -548 Thousand | -139 Thousand | -135 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | -7000.00 |
| Common Stock Issuance | 135 Thousand | 2000.00 | 41.16 Million | 43.79 Million | 574 Thousand | - |
| Other Financing Activities | -24 Thousand | -523 Thousand | 41.16 Million | 43.79 Million | 13 Thousand | 2.05 Million |
| Accounts receivables | -510 Thousand | 14.8 Million | -14.78 Million | -14.8 Million | -103 Thousand | 295 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 91.6 Million | -64 Thousand | 165 Thousand | -360 Thousand | 570 Thousand | 167 Thousand |
| Cash at beginning of period | 57 Million | 78.49 Million | 31.92 Million | 31.58 Million | 40 Million | 57.43 Million |
| Cash at end of period | 51.56 Million | 57 Million | 78.49 Million | 78.49 Million | 31.92 Million | 40 Million |
| Capital Expenditure | -68 Thousand | -249 Thousand | -166 Thousand | -801 Thousand | -280 Thousand | -155 Thousand |
| Effect of forex changes on cash | -2.59 Million | 1.74 Million | -1.55 Million | -1.57 Million | 52 Thousand | -71 Thousand |
| Net cash flow / Change in cash | -5.44 Million | -21.48 Million | 46.56 Million | 46.9 Million | -8.08 Million | -17.42 Million |
| Free Cash Flow | 72.95 Million | 775 Thousand | -16.35 Million | -61.2 Million | -13.58 Million | -14.27 Million |
3434
0720
THMO
MRRTY
NWH-UN
3999